Tagged with TITCK

Can Turkey Become a True Clinical Trials Hub?

Turkey Can Turkey Become a True Clinical Trials Hub?

Turkey Becoming the clinical trials country leader in the region has been set as a primary goal for Turkey’s pharma industry to achieve global competitiveness. The government’s strategy is to increase its share of global clinical studies both in numbers and investment. Today, the country occupies the 26th position with 529…

Solidarity: How COVID-19 Brought the Turkish R&D Ecosystem Together

Turkey Solidarity: How COVID-19 Brought the Turkish R&D Ecosystem Together

Turkey As an upper-middle-income country with an emerging economy, Turkey could not invest billions in COVID-19 vaccine R&D, but a strong research ecosystem and willing industry allowed it to kickstart multiple vaccine and drug projects, discovering a new collaborative model along the way. The responsibility for coordinating Turkey’s research and…

Top 2021 Insights from Global Regulators

Global Top 2021 Insights from Global Regulators

Global Over the past 12 months, PharmaBoardroom has spoken to the heads of several key regulatory bodies across the world. While the approval processes for COVID-19 vaccines have evidently been top of their priority lists, other key topics discussed included the potential of data and AI to change the drug approval…

Tolga Karakan – President, Turkish Medicines and Medical Devices Agency (TITCK)

Turkey Tolga Karakan – President, Turkish Medicines and Medical Devices Agency (TITCK)

Turkey TITCK is the regulatory agency in charge of ensuring the safety of medicines, health products, cosmetics, and personal care products in Turkey. Its recently appointed president, Dr Tolga Karakan, discusses the agency’s work with the WHO, ICH and EU Commission to help Turkish patients and consumers, their experience with emergency…

Hakkı Gürsöz, President, TiTCK, Turkey

Turkey Hakkı Gürsöz, President, TiTCK, Turkey

Turkey Dr. Hakkı Gürsöz, president of the Turkish Medicines and Medical Devices Agency (TiTCK), provides insights into recent localization and pricing policies and delivers strong messages to both domestic and foreign companies operating in Turkey while underlining TiTCK’s ambitions to work hand-in-hand with the industry, the world’s most respected regulatory authorities…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page